About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Alliance Statistics and Data Center
›
top-articles
Alliance Statistics and Data Center
29
(top 2%)
papers
1.4K
(top 2%)
citations
19
(top 2%)
h
-index
27
(top 2%)
g
-index
29
all documents
1.5K
doc citations
552
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer
Nature Genetics
2014
294
2
VATS Lobectomy Has Better Perioperative Outcomes Than Open Lobectomy: CALGB 31001, an Ancillary Analysis of CALGB 140202 (Alliance)
Annals of Thoracic Surgery
2015
170
3
Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates
Annals of Surgery
2015
154
4
CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer
Gastroenterology
2014
118
5
A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)
Annals of Oncology
2017
72
6
Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance)
PLoS ONE
2014
65
7
Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503
Journal of Thoracic and Cardiovascular Surgery
2017
64
8
Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)
Breast Cancer Research and Treatment
2016
63
9
Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance)
Cancer Epidemiology Biomarkers and Prevention
2018
52
10
CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells
Cancer Immunology Research
2014
48
11
Clinical impact of
ABL1
kinase domain mutations and
IKZF1
deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665
Leukemia and Lymphoma
2016
45
12
Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance)
Annals of Oncology
2017
43
13
Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501)
Leukemia and Lymphoma
2015
36
14
Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance)
Pharmacogenomics Journal
2014
33
15
Impact of Physical Activity After Cancer Diagnosis on Survival in Patients With Recurrent Colon Cancer: Findings From CALGB 89803/Alliance
Clinical Colorectal Cancer
2013
31
16
The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance)
Leukemia and Lymphoma
2013
27
17
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)
Cancer Chemotherapy and Pharmacology
2014
27
18
A randomized trial of diet in men with early stage prostate cancer on active surveillance: Rationale and design of the Men's Eating and Living (MEAL) Study (CALGB 70807 [Alliance])
Contemporary Clinical Trials
2014
27
19
Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci
Pharmacogenetics and Genomics
2018
26
20
A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)
Investigational New Drugs
2013
21
21
The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance)
Journal of Geriatric Oncology
2018
14
22
A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502
Blood
2012
14
23
Long‐term outcomes for newly‐diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of
CALGB
(Alliance) 10301, a multicentre phase
II
study
British Journal of Haematology
2015
10
24
Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative)
Journal of the American College of Surgeons
2017
8
25
Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome:
CALGB
10105 (
A
lliance)
British Journal of Clinical Pharmacology
2014
7
26
Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)
Blood
2013
2
27
FINAL RESULTS OF CALGB 50803 (ALLIANCE): A PHASE 2 TRIAL OF LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA
Hematological Oncology
2017
1
28
Obesity Is An Adverse Prognostic Factor For Overall and Disease-Free Survival In Adult Acute Promyelocytic Leukemia But Not In Acute Myeloid Leukemia: A Pooled Analysis From Four Alliance Prospective Studies
Blood
2013
1
29
Abstract 3388: Genetic prediction of VEGF-A plasma levels in cancer patients
2016
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.